Literature DB >> 6159498

Potentiation of antitumor effect of virus-induced interferon by mouse immune interferon preparations.

W R Fleischmann, K M Kleyn, S Baron.   

Abstract

In inbred DBA/2 mice, the antitumor activities of separate and combined preparations of mouse immune interferon and mouse virus-induced interferon on the development of P388 tumors were studied. Immune interferon alone (25 U/day) did not affect tumor development. Virus-induced interferon alone (25,000 U/day) delayed tumor development and increased survival time. The mouse immune interferon preparations significantly enhanced or potentiated the antitumor effects of mouse virus-induced interferon when the interferons were used in combined therapy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6159498

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  20 in total

1.  Recombinant interferon-gamma and chemotherapy with isoniazid and rifampicin in experimental murine tuberculosis.

Authors:  M Khor; D B Lowrie; A R Coates; D A Mitchison
Journal:  Br J Exp Pathol       Date:  1986-08

2.  Phase I/II study of recombinant interferon alpha and gamma in advanced progressive renal-cell carcinoma.

Authors:  P H de Mulder; F M Debruyne; M P Franssen; A D Geboers; S Strijk; A G Reintjes; W H Doesburg; O Damsma
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

Review 3.  Alpha interferon: a look to the future.

Authors:  E M Bonnem
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

Review 4.  Interferons and interferon inducers: development of clinical usefulness and therapeutic promise.

Authors:  R B Pollard
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

5.  Interferons as antitumor agents.

Authors:  H Kirchner
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

6.  Stimulation natural cytotoxic activity in mixed cell cultures and by culture supernatants containing interferon.

Authors:  M R Potter; M Moore; A G Morris
Journal:  Immunology       Date:  1982-06       Impact factor: 7.397

7.  Clinical effect of interferon in malignant brain tumours.

Authors:  M Nagai; T Arai
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042

8.  Characteristics of in vitro antiproliferation activity of human interferon-beta.

Authors:  T Kataoka; F Oh-hashi; Y Sakurai; N Ida
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

9.  Molecular cloning of human immune interferon cDNA and its expression in eukaryotic cells.

Authors:  R Devos; H Cheroutre; Y Taya; W Degrave; H Van Heuverswyn; W Fiers
Journal:  Nucleic Acids Res       Date:  1982-04-24       Impact factor: 16.971

10.  Stimulation of human gamma interferon production by diterpene esters.

Authors:  Y K Yip; R H Pang; J D Oppenheim; M S Nachbar; D Henriksen; I Zerebeckyj-Eckhardt; J Vilcek
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.